NCT01183871

Brief Summary

The investigators hypothesize that the lung resection would be associated with lower jugular bulb oxygen saturation in patients with severe pulmonary dysfunction than in patients with healthy lung functions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Feb 2010

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

March 26, 2012

Status Verified

March 1, 2012

Enrollment Period

1.8 years

First QC Date

August 12, 2010

Last Update Submit

March 22, 2012

Conditions

Keywords

Cerebral oxygenationthoracotomylung resectionpulmonary dysfunction

Outcome Measures

Primary Outcomes (1)

  • jugular bulb oxygenation

    jugular bulb oxygen saturation (SjvO2), estimated cerebral metabolic rate of oxygen \[CMRO2\], cerebral extraction of oxygen \[CEO2\], cerebral blood flow equivalent \[CBFE\], and arterial to jugular difference in oxygen content (AjvDO2)

    before (baseline) and15 min after induction of anesthesia during two-lung ventilation, 15, 30, 60 min after OLV, and 15 min after resuming of two-lung ventilation (TLV), and 1, 4, 6, 12, 18 and 24 hrs after recovery.

Secondary Outcomes (1)

  • Respiratory and Hemodynamic Data

    baseline and15 min after induction of anesthesia during two-lung ventilation,1, 4, 6, 12, 18 and 24 hrs after recovery.

Study Arms (4)

good pulmonary functions (group 1)

ACTIVE COMPARATOR

FVC and/or FEV1 of 80% of predicted or more

Procedure: Monitoring of cerebral oxygenation

mild pulmonary dysfunction (group 2)

ACTIVE COMPARATOR

FVC and/or FEV1 of 70%-79% of predicted

Procedure: Monitoring of cerebral oxygenation

moderate pulmonary dysfunction (group 3)

ACTIVE COMPARATOR

FVC and/or FEV1 of 60%-69% of predicted

Procedure: Monitoring of cerebral oxygenation

severe pulmonary dysfunction (group 4)

ACTIVE COMPARATOR

FVC and/or FEV1 of 50%-59% of predicted

Procedure: Monitoring of cerebral oxygenation

Interventions

The internal jugular vein will be cannulated using ultrasound guidance in a cephalad direction, using the Seldinger J-shaped guidewire and it will be advanced only for 2-3 cm beyond the needle insertion site to avoid vascular injury to the jugular bulb. At which point the catheter is advanced until resistance is met at the jugular bulb, usually about 15 cm. The catheter is then pulled back 0.5-1.0 cm so that the catheter does not continue to abut the roof of the jugular bulb and to minimize the cephalad vascular impact with head movement, thereby reducing the risk of vascular injury. Skull x-ray will be used to confirm placement.

good pulmonary functions (group 1)mild pulmonary dysfunction (group 2)moderate pulmonary dysfunction (group 3)severe pulmonary dysfunction (group 4)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA II-IV
  • Ages 18-60 yrs.
  • Good or impaired pulmonary function tests

You may not qualify if:

  • Decompensated cardiac function (\>New York Heart Association II).
  • Hepatic and renal diseases
  • Arrhythmias
  • Moderate pulmonary hypertension (mean pulmonary artery pressure (MPAP) \>35 mm Hg),
  • Previous history of pneumonectomy, bilobectomy or lobectomy
  • Cervical spine injury
  • Tracheostomy
  • Coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Fahd hospital of the University of Dammam

Khobar, Eastern Province, 31952, Saudi Arabia

Location

Study Officials

  • Mohamed R El Tahan, M.D.

    King Faisal University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2010

First Posted

August 18, 2010

Study Start

February 1, 2010

Primary Completion

December 1, 2011

Study Completion

February 1, 2012

Last Updated

March 26, 2012

Record last verified: 2012-03

Locations